Doctor Mau Informa
by Sonoro | Dr. Mauricio González Arias
Is this your podcast?Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Total monthly reach
Estimated from 8 chart positions in 8 markets.
By chart position
- 🇲🇽MX · Medicine#2300K to 800K
- 🇪🇸ES · Medicine#2530K to 100K
- 🇰🇷KR · Medicine#7110K to 30K
- 🇨🇱CL · Medicine#5100K to 300K
- 🇦🇷AR · Medicine#930K to 100K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
265K to 767K🎙 ~2x weekly·70 episodes·Last published 2mo ago - Monthly Reach
Unique listeners across all episodes (30 days)
531K to 1.5M🇲🇽52%🇨🇱20%🇪🇸7%+5 more - Active Followers
Loyal subscribers who consistently listen
159K to 460K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 12 epsHosts
Recent guests
No guests detected in recent episodes.
Recent episodes
Retatrutide: la hormona que aprendimos a controlar
Jun 18, 2026
10m 53s
El entrenamiento de fuerza es endocrinología clínica
Jun 4, 2026
8m 09s
De médico a líder: 5 claves reales
Mar 25, 2026
14m 08s
Roncar no es normal: la condición silenciosa que daña tu corazón
Mar 11, 2026
6m 57s
La prueba de 1 minuto que predice cuánto vivirás
Feb 25, 2026
6m 10s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 6/18/26 | endocrinologyweight loss+4 | — | RetatrutideDoctor Mau Informa+5 | — | Retatrutideglucagón+7 | — | 10m 53s | ||
| 6/4/26 | diabetes type 2prediabetes+4 | — | Asociación Americana de DiabetesACSM | — | diabeteshypertrophy+6 | — | 8m 09s | ||
| 3/25/26 | success in medicinecareer development+3 | — | Doctor Mau InformaArquitecto de Protocolos | — | success in medicinemedical career+3 | — | 14m 08s | ||
| 3/11/26 | Apnea Obstructiva del Sueñosalud del corazón+4 | — | SomnólogoNeumólogo+3 | — | apnea del sueñosalud cardiovascular+3 | — | 6m 57s | ||
| 2/25/26 | longevityhealth+4 | — | — | — | longevitySit-to-Stand test+3 | — | 6m 10s | ||
| 12/10/25 | GLP-1 medicationshealth benefits+4 | — | OzempicWegovy+2 | — | GLP-1Ozempic+6 | — | 9m 56s | ||
| 11/26/25 | hígado grasosalud+4 | — | Doctor Mau InformaSonoro | — | hígado grasosalud+5 | — | 9m 29s | ||
| 11/19/25 | MounjaroTirzepatida+4 | — | MounjaroTirzepatida+1 | — | MounjaroTirzepatida+5 | — | 11m 15s | ||
| 4/30/25 | Ozempicmetabolism+3 | — | OzempicJ Clin Invest+1 | — | Ozempicsemaglutida+5 | — | 6m 00s | ||
| 4/23/25 | cognitive healthbrain improvement+3 | — | The LancetPubMed | — | brain healthcognitive decline+3 | — | 8m 53s | ||
| 1/29/25 | nutritionskin health+4 | — | SonoroNutrition and Health+3 | — | anti-agingskin nutrition+3 | — | 12m 11s | ||
| 1/22/25 | omega-3pregnancy health+3 | — | World Journal of Advanced Research and ReviewsInternational Journal of Obstetrics and Gynecology+4 | — | omega-3pregnancy+5 | — | 10m 16s |
Showing 12 of 12
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.
Chart history for Doctor Mau Informa
Peaked at #2 in Mexico, top 10 in 3 of 13 tracked markets, currently #2 in Mexico.
| Market | Genre | Peak | Current | Trend |
|---|---|---|---|---|
| Mexico | — | #2 | #2 | — |
| CL | — | #5 | #5 | — |
| AR | — | #9 | #9 | — |
| CO | — | #19 | #19 | — |
| PE | — | #20 | #20 | — |
| Spain | — | #25 | #25 | — |
| Mexico | — | #33 | #33 | — |
| CL | — | #48 | #48 | — |
| South Korea | — | #71 | #71 | — |
| CH | — | #150 | #150 | — |
| PE | — | #159 | #159 | — |
| Spain | — | #160 | #160 | — |
| AR | — | #163 | #163 | — |
Chart Positions
13 placements across 8 markets.
Chart Positions
13 placements across 8 markets.